Indian government in talks with ASEAN, Africa and SAARC countries

30-Nov-2015 # Wider Regions Source: The Hans India

With an aim to help Indian drug makers to save cost on upgrading to international standards, India is nudging various semi-regulated markets like Myanmar and Kenya to accept its drug standards, instead of British Pharmacopoeia (BP) or the United States Pharmacopoeia (USP). Extending its support to this initiative, Pharmexcil has invited 10-15 drug regulatory heads from various countries to participate in the Indian Pharmaceutical Congress at Mysore next month.

Read Full Article..